Net sales for DJO’s bracing and vascular segment increased 9.6 percent in the third quarter, while net sales for the recovery sciences segment fell by 1.3 percent. The company’s surgical implant segment saw a 12.9 percent increase to $17.2 million.
More Articles on Orthopedic Devices:
Smith & Nephew Launches Endobutton
